U.S. Radiopharmaceutical Agents Markets

 


This research service focuses on the U.S. Radiopharmaceutical Agents markets, which is segmented into cardiology diagnostics, other diagnostics, FDG, and therapeutic market segments. The research service covers the markets for these radiopharmaceutical agents over an eleven year period, from 2004 to 2014, with the base year being 2007. The research service provides a comprehensive analysis and forecasts for revenue by segment, demand analysis including data on procedure volumes, procedure types, and installed base, competitive structure and market share analysis, and product analysis. Market drivers, restraints, and challenges have also been identified along with strategic recommendations.

Regular Price: USD 6,950

Special Price USD 4,865

30% OFF

* Required Fields

Regular Price: USD 6,950

Special Price USD 4,865

PAY BY INVOICE

Be the first to review this product

Table of Contents

U.S. Radiopharmaceutical Agents Markets, Executive SummaryExecutive SummaryExecutive SummaryU.S. Radiopharmaceutical Agents Markets, Total U.S. Radiopharmaceutical Agents MarketMarket OverviewIntroductionScope and SegmentationResearch MethodologyBase Market AssumptionsForecast MethodologyRestraints in ForecastsMarket DynamicsMarket Engineering MeasurementsIndustry ChallengesStrategic RecommendationsRevenue ForecastsCompetitive AnalysisCompetitive StructureU.S. Radiopharmaceutical Agents Markets, U.S. Diagnostic Radiopharmaceutical Agents MarketDiagnostic Radiopharmaceutical Agents OverviewIntroductionScope and SegmentationMarket OverviewDiagnostic Radiopharmaceutical Agents Market DynamicsMarket Engineering MeasurementsMarket DriversMarket RestraintsDiagnostic Radiopharmaceutical Agents ForecastsRevenue ForecastsInstalled BaseProcedure Volume AnalysisDiagnostic Radiopharmaceutical Agents Competitive AnalysisCompetitive StructureMarket Share AnalysisCardiology Diagnostic Radiopharmaceutical Agents Forecasts and TrendsIntroductionMarket Engineering AnalysisRevenue ForecastsProcedure Volume AnalysisCardiology Diagnostic Radiopharmaceutical Agents Competitive AnalysisCompetitive StructureMarket Share AnalysisProduct Analysis - Existing AgentsProduct Analysis - Emerging AgentsOther Diagnostic Radiopharmaceutical Agents Forecasts and TrendsIntroductionMarket Engineering AnalysisRevenue ForecastsProcedure Volume AnalysisOther Diagnostic Radiopharmaceutical Agents Competitive AnalysisCompetitive StructureMarket Share AnalysisProduct Analysis - Existing AgentsProduct Analysis - Emerging AgentsU.S. Radiopharmaceutical Agents Markets, U.S. FDG MarketFDG Market OverviewIntroductionFDG Market DynamicsMarket Engineering AnalysisMarket DriversMarket RestraintsFDG Forecasts and TrendsRevenue ForecastsProcedure Volume AnalysisFDG Distribution TrendsFDG Competitive AnalysisCompetitive StructureMarket Share AnalysisU.S. Radiopharmaceutical Agents Markets, U.S. Therapeutic Radiopharmaceutical Agents MarketTherapeutic Radiopharmaceutical Agents OverviewIntroductionMarket OverviewTherapeutic Radiopharmaceuitcal Agents Market DynamicsMarket Engineering AnalysisMarket DriversMarket RestraintsTherapeutic Radiopharmaceutical Agents ForecastsRevenue ForecastsTherapeutic Radiopharmaceutical Agents Competitive AnalysisCompetitive StructureMarket Share AnalysisProduct Analysis - Existing AgentsProduct Analysis - Emerging AgentsU.S. Radiopharmaceutical Agents Markets, Decision Support DatabaseDecision Support DatabaseGlobal Incidence Rate of Myocardial InfarctionMortality Due to Brain CancerPrevalance of Alzheimer's DiseaseNumber of Hospitals




Related Research

Release Date : 11-Aug-17

Region : North America

Release Date : 10-Aug-17

Region : North America

Release Date : 09-Aug-17

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.